376 related articles for article (PubMed ID: 20383180)
21. Phosphorylation and linear ubiquitin direct A20 inhibition of inflammation.
Wertz IE; Newton K; Seshasayee D; Kusam S; Lam C; Zhang J; Popovych N; Helgason E; Schoeffler A; Jeet S; Ramamoorthi N; Kategaya L; Newman RJ; Horikawa K; Dugger D; Sandoval W; Mukund S; Zindal A; Martin F; Quan C; Tom J; Fairbrother WJ; Townsend M; Warming S; DeVoss J; Liu J; Dueber E; Caplazi P; Lee WP; Goodnow CC; Balazs M; Yu K; Kolumam G; Dixit VM
Nature; 2015 Dec; 528(7582):370-5. PubMed ID: 26649818
[TBL] [Abstract][Full Text] [Related]
22. Expression of the nuclear factor-κB inhibitor A20 is altered in the cystic fibrosis epithelium.
Kelly C; Williams MT; Mitchell K; Elborn JS; Ennis M; Schock BC
Eur Respir J; 2013 Jun; 41(6):1315-23. PubMed ID: 23018911
[TBL] [Abstract][Full Text] [Related]
23. Frequent inactivation of A20 in B-cell lymphomas.
Kato M; Sanada M; Kato I; Sato Y; Takita J; Takeuchi K; Niwa A; Chen Y; Nakazaki K; Nomoto J; Asakura Y; Muto S; Tamura A; Iio M; Akatsuka Y; Hayashi Y; Mori H; Igarashi T; Kurokawa M; Chiba S; Mori S; Ishikawa Y; Okamoto K; Tobinai K; Nakagama H; Nakahata T; Yoshino T; Kobayashi Y; Ogawa S
Nature; 2009 Jun; 459(7247):712-6. PubMed ID: 19412163
[TBL] [Abstract][Full Text] [Related]
24. [Structural biology of ubiquitin signaling].
Nishimasu H; Ishitani R; Nureki O
Seikagaku; 2013 Jun; 85(6):423-9. PubMed ID: 23875469
[No Abstract] [Full Text] [Related]
25. The seventh zinc finger motif of A20 is required for the suppression of TNF-α-induced apoptosis.
Yamaguchi N; Yamaguchi N
FEBS Lett; 2015 May; 589(12):1369-75. PubMed ID: 25911380
[TBL] [Abstract][Full Text] [Related]
26. Expression, biological activities and mechanisms of action of A20 (TNFAIP3).
Verstrepen L; Verhelst K; van Loo G; Carpentier I; Ley SC; Beyaert R
Biochem Pharmacol; 2010 Dec; 80(12):2009-20. PubMed ID: 20599425
[TBL] [Abstract][Full Text] [Related]
27. Cystic Fibrosis from Laboratory to Bedside: The Role of A20 in NF-κB-Mediated Inflammation.
Bannon A; Zhang SD; Schock BC; Ennis M
Med Princ Pract; 2015; 24(4):301-10. PubMed ID: 25925366
[TBL] [Abstract][Full Text] [Related]
28. Comparative distribution of protein components of the A20 ubiquitin-editing complex in normal human brain.
Pranski EL; Van Sanford CD; Dalal NV; Orr AL; Karmali D; Cooper DS; Costa N; Heilman CJ; Gearing M; Lah JJ; Levey AI; Betarbet RS
Neurosci Lett; 2012 Jun; 520(1):104-9. PubMed ID: 22634524
[TBL] [Abstract][Full Text] [Related]
29. Negative regulation of the retinoic acid-inducible gene I-induced antiviral state by the ubiquitin-editing protein A20.
Lin R; Yang L; Nakhaei P; Sun Q; Sharif-Askari E; Julkunen I; Hiscott J
J Biol Chem; 2006 Jan; 281(4):2095-103. PubMed ID: 16306043
[TBL] [Abstract][Full Text] [Related]
30. A20--a bipartite ubiquitin editing enzyme with immunoregulatory potential.
Wertz I; Dixit V
Adv Exp Med Biol; 2014; 809():1-12. PubMed ID: 25302362
[TBL] [Abstract][Full Text] [Related]
31. Pathogen-induced ubiquitin-editing enzyme A20 bifunctionally shuts off NF-κB and caspase-8-dependent apoptotic cell death.
Lim MCC; Maubach G; Sokolova O; Feige MH; Diezko R; Buchbinder J; Backert S; Schlüter D; Lavrik IN; Naumann M
Cell Death Differ; 2017 Sep; 24(9):1621-1631. PubMed ID: 28574503
[TBL] [Abstract][Full Text] [Related]
32. A20/TNFAIP3 Regulates the DNA Damage Response and Mediates Tumor Cell Resistance to DNA-Damaging Therapy.
Yang C; Zang W; Tang Z; Ji Y; Xu R; Yang Y; Luo A; Hu B; Zhang Z; Liu Z; Zheng X
Cancer Res; 2018 Feb; 78(4):1069-1082. PubMed ID: 29233925
[TBL] [Abstract][Full Text] [Related]
33. Two distinct ubiquitin-binding motifs in A20 mediate its anti-inflammatory and cell-protective activities.
Martens A; Priem D; Hoste E; Vetters J; Rennen S; Catrysse L; Voet S; Deelen L; Sze M; Vikkula H; Slowicka K; Hochepied T; Iliaki K; Wullaert A; Janssens S; Lamkanfi M; Beyaert R; Armaka M; Bertrand MJM; van Loo G
Nat Immunol; 2020 Apr; 21(4):381-387. PubMed ID: 32205881
[TBL] [Abstract][Full Text] [Related]
34. Genetic relationships between A20/TNFAIP3, chronic inflammation and autoimmune disease.
Vereecke L; Beyaert R; van Loo G
Biochem Soc Trans; 2011 Aug; 39(4):1086-91. PubMed ID: 21787353
[TBL] [Abstract][Full Text] [Related]
35. A20 takes on tumors: tumor suppression by an ubiquitin-editing enzyme.
Malynn BA; Ma A
J Exp Med; 2009 May; 206(5):977-80. PubMed ID: 19380636
[TBL] [Abstract][Full Text] [Related]
36. The Ubiquitin System and A20: Implications in Health and Disease.
Mooney EC; Sahingur SE
J Dent Res; 2021 Jan; 100(1):10-20. PubMed ID: 32853526
[TBL] [Abstract][Full Text] [Related]
37. Tumor suppressor TNFAIP3 (A20) is frequently deleted in Sézary syndrome.
Braun FC; Grabarczyk P; Möbs M; Braun FK; Eberle J; Beyer M; Sterry W; Busse F; Schröder J; Delin M; Przybylski GK; Schmidt CA
Leukemia; 2011 Sep; 25(9):1494-501. PubMed ID: 21625233
[TBL] [Abstract][Full Text] [Related]
38. Regulation of Toll-like receptor 4 signalling by A20 zinc finger protein.
O'Reilly SM; Moynagh PN
Biochem Biophys Res Commun; 2003 Apr; 303(2):586-93. PubMed ID: 12659860
[TBL] [Abstract][Full Text] [Related]
39. CYLD: a tumor suppressor deubiquitinase regulating NF-kappaB activation and diverse biological processes.
Sun SC
Cell Death Differ; 2010 Jan; 17(1):25-34. PubMed ID: 19373246
[TBL] [Abstract][Full Text] [Related]
40. [Immune regulation role of A20 and its clinical significance].
Li YQ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Aug; 19(4):851-6. PubMed ID: 21867600
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
